Advertisement
Screener

ENDONOVO THERAPEUTICS, INC. (ENDV) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price

1.6 / 5 stars · 18/56 Roast Me

ENDONOVO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price

ENDONOVO THERAPEUTICS, INC. (ENDV) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $0.15 per share as of 2020-12-31, per its 10-K filed 2022-04-14.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2022-04-14

  • 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.15.
  • 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $11.60.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
2020-12-31$0.15
10-K · filed 2022-04-14
2019-12-31$11.60
10-K · filed 2021-04-13